Therapeutics , Targets , and Chemical Biology High-Throughput Tyrosine Kinase Activity Pro fi ling Identi fi es FAK as a Candidate Therapeutic Target in Ewing Sarcoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors.

  2012cited by this paper
• Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.

  2012cited by this paper
• Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors

  2012cited by this paper
• Targeting MET in cancer: rationale and progress

  2012cited by this paper
• Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.

  2012cited by this paper
• A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.

  2012cited by this paper
• Risk of recurrence and survival after relapse in patients with Ewing sarcoma

  2011cited by this paper
• Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma

  2011cited by this paper
• R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.

  2011cited by this paper
• A Novel Retinoblastoma Therapy from Genomic and Epigenetic Analyses

  2011cited by this paper
• Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.

  2010cited by this paper
• Ewing Sarcoma Demonstrates Racial Disparities in Incidence-related and Sex-related Differences in Outcome: An Analysis of 1631 Cases From the SEER Database, 1973-2005

  2010cited by this paper
• Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

  2009cited by this paper
• Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in Ewing family of tumors.

  2009cited by this paper
• Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy

  2009cited by this paper
• MEK1 mutations confer resistance to MEK and B-RAF inhibition

  2009cited by this paper
• Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.

  2009cited by this paper
• Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.

  2008influential reference
• Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.

  2008cited by this paper
• FAK association with multiple signal proteins mediates pressure‐induced colon cancer cell adhesion via a Src‐dependent PI3K/Akt pathway

  2007cited by this paper
• Insulin-Like Growth Factor I Receptor Pathway Inhibition by ADW742, Alone or in Combination with Imatinib, Doxorubicin, or Vincristine, Is a Novel Therapeutic Approach in Ewing Tumor

  2006cited by this paper
• Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number

  2006cited by this paper
• Focal adhesion kinase: in command and control of cell motility

  2005cited by this paper
• Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells.

  2005cited by this paper
• Prediction of high risk Ewing's sarcoma by gene expression profiling

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

  2003cited by this paper
• Differential regulation of cell motility and invasion by FAK

  2003cited by this paper
• Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

  2003cited by this paper
• Newly established Askin tumor cell line and overexpression of focal adhesion kinase in Ewing sarcoma family of tumors cell lines.

  2003cited by this paper
• Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation

  2003cited by this paper
• Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo

  2002cited by this paper
• Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

  2002cited by this paper
• Urokinase-type Plasminogen Activator Stimulates the Ras/Extracellular Signal-regulated Kinase (ERK) Signaling Pathway and MCF-7 Cell Migration by a Mechanism That Requires Focal Adhesion Kinase, Src, and Shc

  2000cited by this paper
• Focal adhesion kinase promotes phospholipase C-gamma1 activity.

  1999cited by this paper
• Association of Focal Adhesion Kinase with Grb7 and Its Role in Cell Migration*

  1999cited by this paper
• Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma

  1999cited by this paper
• Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells

  1999cited by this paper
• Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.

  1999cited by this paper
• Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma.

  1998cited by this paper
• Identification of p130Cas as a Mediator of Focal Adhesion Kinase–promoted Cell Migration

  1998cited by this paper
• Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target.

  1996cited by this paper
• Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells.

  1996cited by this paper
• Phosphorylation of Tyrosine 397 in Focal Adhesion Kinase Is Required for Binding Phosphatidylinositol 3-Kinase*

  1996cited by this paper
• Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase

  1994cited by this paper
• Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src

  1994cited by this paper
• The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

  1993cited by this paper
• pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.

  1992cited by this paper

• No citing papers are available for this paper.